ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Data Mining Historical Chinese Medical Recipe Collections and Nuclear Receptor Profiling Identify Plant Fractions that Modulate Glucocorticoid Receptor Activity
Provisionally accepted- 1Charité University Medicine Berlin, Berlin, Germany
- 2Precision Medicine Lab BV, Oss, Netherlands
- 3Bicoll Biotechnology Co Ltd, Shanghai, China
- 4Bicoll GmbH, Planegg, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective Glucocorticoids (GCs) play a prominent role in the management of chronic inflammatory diseases like rheumatoid arthritis and psoriatic arthritis, but their use is associated with various adverse effects. The therapeutic and adverse effects of GCs can be partly explained by modes of engagement with their target, the glucocorticoid receptor (GR). Identifying compounds that modulate GR through alternative mechanisms of action may provide a strategy to decouple therapeutic efficacy from side effects. Historical manuscripts on Chinese pharmacotherapy, which document the empirical use of natural products in treating inflammatory diseases, represent an underexplored source in drug discovery. These texts offer a historical library of plant materials and their metabolites, enabling strategic pre-selection of plant candidates for GR-targeted screening. Method This study utilizes the Chinese Historical Healthcare Manuscripts Database, a newly compiled corpus comprising over 41,000 medical recipes from 227 historical Chinese manuscripts, to identify plant-based treatments for rheumatoid arthritis and psoriatic arthritis. Pareto front analysis, a multi-objective optimization method, was applied to 1,897 relevant recipes to identify plants that consistently ranked high across multiple metrics, suggesting their effectiveness in historical practice. The results were evaluated by comparison with modern Chinese materia medica dictionaries. Extracts from ten of these resulting plants underwent fractionation and were screened for GR modulation using Nuclear Receptor Activity Profiling (NAPing). Findings Pareto front analysis identified 32 botanical drugs statistically associated with historical disease indications resembling rheumatoid arthritis, psoriatic arthritis, and psoriasis. Nineteen of these are explicitly described in Chinese materia medica dictionaries for the treatment of such diseases. None of the plant fractions tested by NAPing replicated classical GC-induced GR-coregulator binding, but three induced unique binding interactions, suggesting alternative GR modulation mechanisms. Conclusion This study illustrates how combining data mining of historical pharmaceutical recipes with molecular screening can accelerate the discovery of new and possibly safer GR modulators. Such approaches may inform future translational strategies for treating chronic inflammatory diseases.
Keywords: Glucocorticoid receptor, Traditional Chinese Medicine, Natural Products, data-mining, Pareto front, Inflammation, Rheumatoid arthritis, psoriatic arthritis
Received: 12 Aug 2025; Accepted: 27 Nov 2025.
Copyright: © 2025 Prackwieser, Houtman, Kievitz, Melchers, Guan, Seifert, Konietschke, Lamottke, Unschuld and Kirk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Joachim Prackwieser
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
